HmmmmWow....management walking their talk by undertaking an accreative aquistion of 5% increase in revenue and 10% increase in EBITDA for $875G all cash ( no dilution) trading at 4X/ EBITDA when peers average 12X .......and the stock pretty much treds water.
Shows just how under-followed this stock is.......